Relationships between the pharmaceutical industry and patient groups are also coming under increasing scrutiny. Merck notes that while disclosure of grants to patient organisations has been mandatory in Europe since March 2009, it has voluntarily disclosed such payments in Europe, the Middle East and Africa since 2008. It began reporting such payments in Canada last year. 2 Meanwhile, the Indian Medical Council recently introduced new regulations banning doctors from receiving gifts, travel and hospitality from pharmaceutical or allied healthcare companies.
Doctors also must not endorse any drug or product in public.
The regulations state, 'Any study conducted on the efficacy or otherwise of such products shall be presented to and/or through appropriate scientific bodies or published in appropriate scientific journals in a proper way'. 3 ln Australia, there is no systematic mechanism for ensuring full and open disclosure of financial ties, despite concern that self-regulation by the profession has been largely ineffective and that 'medicine is facing a credibility problem of unheralded proportions'. 4 The Medicines Australia Code of Conduct requires member companies to reveal some details of sponsored events, but these reporting requirements could be strengthened and extended. 5 clinicians and health services could consider voluntarily making such declarations. It has also been suggested that patients should consider asking clinicians whether they receive payments or gifts from industry. 6 Views are mixed, however, about the likely impact of increased disclosure. Some argue that transparency alone is not sufficient in every situation, and that, for example, editorials, reviews and guidelines should be written by experts without any conflicts of interest. 7 In the wake of revelations about commercial ties of experts involved in setting the World Health Organization's 
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Some authors argue that encouraging greater transparency is the wrong solution, and is comparable to asking doctors in the 1800s to declare whether they washed their hands between doing autopsies and delivering babies. 9 They cite the limited evidence 10 
